Ke Wang

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 20

Top Venues

Signal transduction and targeted therapy

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Biomolecules

This page only lists publications with an associated author ORCID identifier.

Publications

Ke Wang, Xiaohong Chen, Peng Lin, Jiao Wu, Qiang Huang, Zhi-Nan Chen, Jiale Tian, Hao Wang, Ye Tian, Mingyan Shi, Meirui Qian, Bengang Hui, Yumeng Zhu, Ling Li, Rui Yao, Huijie Bian, Ping Zhu, Ruo Chen, Liang Chen
CD147-K148me2-Driven Tumor Cell-Macrophage Crosstalk Provokes NSCLC Immunosuppression via the CCL5/CCR5 Axis. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (29) (2024)
Yixiao Bin, Sanhua Wei, Ruo Chen, Haowei Zhang, Jing Ren, Peijuan Liu, Zhiqian Xin, Tianjiao Zhang, Haijiao Yang, Ke Wang, Zhuan Feng, Xiuxuan Sun, Zhinan Chen, Hai Zhang
Dclre1c -Mutation-Induced Immunocompromised Mice Are a Novel Model for Human Xenograft Research. Biomolecules 14 (2) (2024)
Ke Wang, Xiaohong Chen, Peng Lin, Jiao Wu, Qiang Huang, Zhi-Nan Chen, Jiale Tian, Hao Wang, Ye Tian, Mingyan Shi, Meirui Qian, Bengang Hui, Yumeng Zhu, Ling Li, Rui Yao, Huijie Bian, Ping Zhu, Ruo Chen, Liang Chen
CD147-K148me2-Driven Tumor Cell-Macrophage Crosstalk Provokes NSCLC Immunosuppression via the CCL5/CCR5 Axis. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (29) (2024)
Yixiao Bin, Sanhua Wei, Ruo Chen, Haowei Zhang, Jing Ren, Peijuan Liu, Zhiqian Xin, Tianjiao Zhang, Haijiao Yang, Ke Wang, Zhuan Feng, Xiuxuan Sun, Zhinan Chen, Hai Zhang
Dclre1c -Mutation-Induced Immunocompromised Mice Are a Novel Model for Human Xenograft Research. Biomolecules 14 (2) (2024)
Ke Wang, Xiaohong Chen, Peng Lin, Jiao Wu, Qiang Huang, Zhi-Nan Chen, Jiale Tian, Hao Wang, Ye Tian, Mingyan Shi, Meirui Qian, Bengang Hui, Yumeng Zhu, Ling Li, Rui Yao, Huijie Bian, Ping Zhu, Ruo Chen, Liang Chen
CD147-K148me2-Driven Tumor Cell-Macrophage Crosstalk Provokes NSCLC Immunosuppression via the CCL5/CCR5 Axis. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (29) (2024)
Yixiao Bin, Sanhua Wei, Ruo Chen, Haowei Zhang, Jing Ren, Peijuan Liu, Zhiqian Xin, Tianjiao Zhang, Haijiao Yang, Ke Wang, Zhuan Feng, Xiuxuan Sun, Zhinan Chen, Hai Zhang
Dclre1c -Mutation-Induced Immunocompromised Mice Are a Novel Model for Human Xenograft Research. Biomolecules 14 (2) (2024)
Yixiao Bin, Sanhua Wei, Ruo Chen, Haowei Zhang, Jing Ren, Peijuan Liu, Zhiqian Xin, Tianjiao Zhang, Haijiao Yang, Ke Wang, Zhuan Feng, Xiuxuan Sun, Zhinan Chen, Hai Zhang
Dclre1c -Mutation-Induced Immunocompromised Mice Are a Novel Model for Human Xenograft Research. Biomolecules 14 (2) (2024)
Ke Wang, Xiaohong Chen, Peng Lin, Jiao Wu, Qiang Huang, Zhi-Nan Chen, Jiale Tian, Hao Wang, Ye Tian, Mingyan Shi, Meirui Qian, Bengang Hui, Yumeng Zhu, Ling Li, Rui Yao, Huijie Bian, Ping Zhu, Ruo Chen, Liang Chen
CD147-K148me2-Driven Tumor Cell-Macrophage Crosstalk Provokes NSCLC Immunosuppression via the CCL5/CCR5 Axis. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
Jiejie Geng, Xu Yang, Kun Wang, Ke Wang, Ruo Chen, Zhi-Nan Chen, Chuan Qin, Guizhen Wu, You-Chun Wang, Ke Xu, Peng Du, Jiangning Liu, Shirui Chen, Tao Zhang, Xiuxuan Sun, Ting Guo, Ying Shi, Zheng Zhang, Ding Wei, Peng Lin, Qingyi Wang, Jing Yuan, Jiuxin Qu, Jin Zou, Yingxia Liu, Hongzhou Lu, Ping Zhu, Hui-Jie Bian, Liang Chen
Immunological and metabolic characteristics of the Omicron variants infection. Signal transduction and targeted therapy 8 (1) (2023)
Ke Wang, Yong Zhang, Zhi-Nan Chen
Metabolic interaction: tumor-derived lactate inhibiting CD8 + T cell cytotoxicity in a novel route. Signal transduction and targeted therapy 8 (1) (2023)
Jiejie Geng, Xu Yang, Kun Wang, Ke Wang, Ruo Chen, Zhi-Nan Chen, Chuan Qin, Guizhen Wu, You-Chun Wang, Ke Xu, Peng Du, Jiangning Liu, Shirui Chen, Tao Zhang, Xiuxuan Sun, Ting Guo, Ying Shi, Zheng Zhang, Ding Wei, Peng Lin, Qingyi Wang, Jing Yuan, Jiuxin Qu, Jin Zou, Yingxia Liu, Hongzhou Lu, Ping Zhu, Hui-Jie Bian, Liang Chen
Immunological and metabolic characteristics of the Omicron variants infection. Signal transduction and targeted therapy 8 (1) (2023)
Ke Wang, Yong Zhang, Zhi-Nan Chen
Metabolic interaction: tumor-derived lactate inhibiting CD8 + T cell cytotoxicity in a novel route. Signal transduction and targeted therapy 8 (1) (2023)
Hui-Jie Bian, Liang Chen, Zhao-Hui Zheng, Xiu-Xuan Sun, Jie-Jie Geng, Ruo Chen, Ke Wang, Xu Yang, Shi-Rui Chen, Si-Yu Chen, Rong-Hua Xie, Kui Zhang, Jin-Lin Miao, Jun-Feng Jia, Hao Tang, Shuang-Shuang Liu, Hong-Wei Shi, Yong Yang, Xiao-Chun Chen, Vinay Malhotra, Kulsoom Bano Mehdi, Iffat Khanum, Faisal Mahmood, Saeed Hamid, Claudio Marcel Berdun Stadnik, Kengi Itinose, Caroline Cândida Carvalho de Oliveira, Cesar Dusilek, Lucas Rivabem, Adilson Joaquim Westheimer Cavalcante, Suzara Souto Lopes, Wladmir Faustino Saporito, Fábio José Concilio Fucci, Jesus Abraham Simon-Campos, Ling Wang, Lin-Na Liu, Qing-Yi Wang, Ding Wei, Zheng Zhang, Zhi-Nan Chen, Ping Zhu
Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trial. Signal transduction and targeted therapy 8 (1) (2023)
Hui-Jie Bian, Liang Chen, Zhao-Hui Zheng, Xiu-Xuan Sun, Jie-Jie Geng, Ruo Chen, Ke Wang, Xu Yang, Shi-Rui Chen, Si-Yu Chen, Rong-Hua Xie, Kui Zhang, Jin-Lin Miao, Jun-Feng Jia, Hao Tang, Shuang-Shuang Liu, Hong-Wei Shi, Yong Yang, Xiao-Chun Chen, Vinay Malhotra, Kulsoom Bano Mehdi, Iffat Khanum, Faisal Mahmood, Saeed Hamid, Claudio Marcel Berdun Stadnik, Kengi Itinose, Caroline Cândida Carvalho de Oliveira, Cesar Dusilek, Lucas Rivabem, Adilson Joaquim Westheimer Cavalcante, Suzara Souto Lopes, Wladmir Faustino Saporito, Fábio José Concilio Fucci, Jesus Abraham Simon-Campos, Ling Wang, Lin-Na Liu, Qing-Yi Wang, Ding Wei, Zheng Zhang, Zhi-Nan Chen, Ping Zhu
Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trial. Signal transduction and targeted therapy 8 (1) (2023)
Jiejie Geng, Xu Yang, Kun Wang, Ke Wang, Ruo Chen, Zhi-Nan Chen, Chuan Qin, Guizhen Wu, You-Chun Wang, Ke Xu, Peng Du, Jiangning Liu, Shirui Chen, Tao Zhang, Xiuxuan Sun, Ting Guo, Ying Shi, Zheng Zhang, Ding Wei, Peng Lin, Qingyi Wang, Jing Yuan, Jiuxin Qu, Jin Zou, Yingxia Liu, Hongzhou Lu, Ping Zhu, Hui-Jie Bian, Liang Chen
Immunological and metabolic characteristics of the Omicron variants infection. Signal transduction and targeted therapy 8 (1) (2023)
Jiejie Geng, Xu Yang, Kun Wang, Ke Wang, Ruo Chen, Zhi-Nan Chen, Chuan Qin, Guizhen Wu, You-Chun Wang, Ke Xu, Peng Du, Jiangning Liu, Shirui Chen, Tao Zhang, Xiuxuan Sun, Ting Guo, Ying Shi, Zheng Zhang, Ding Wei, Peng Lin, Qingyi Wang, Jing Yuan, Jiuxin Qu, Jin Zou, Yingxia Liu, Hongzhou Lu, Ping Zhu, Hui-Jie Bian, Liang Chen
Immunological and metabolic characteristics of the Omicron variants infection. Signal transduction and targeted therapy 8 (1) (2023)
Ke Wang, Yong Zhang, Zhi-Nan Chen
Metabolic interaction: tumor-derived lactate inhibiting CD8 + T cell cytotoxicity in a novel route. Signal transduction and targeted therapy 8 (1) (2023)
Hui-Jie Bian, Liang Chen, Zhao-Hui Zheng, Xiu-Xuan Sun, Jie-Jie Geng, Ruo Chen, Ke Wang, Xu Yang, Shi-Rui Chen, Si-Yu Chen, Rong-Hua Xie, Kui Zhang, Jin-Lin Miao, Jun-Feng Jia, Hao Tang, Shuang-Shuang Liu, Hong-Wei Shi, Yong Yang, Xiao-Chun Chen, Vinay Malhotra, Kulsoom Bano Mehdi, Iffat Khanum, Faisal Mahmood, Saeed Hamid, Claudio Marcel Berdun Stadnik, Kengi Itinose, Caroline Cândida Carvalho de Oliveira, Cesar Dusilek, Lucas Rivabem, Adilson Joaquim Westheimer Cavalcante, Suzara Souto Lopes, Wladmir Faustino Saporito, Fábio José Concilio Fucci, Jesus Abraham Simon-Campos, Ling Wang, Lin-Na Liu, Qing-Yi Wang, Ding Wei, Zheng Zhang, Zhi-Nan Chen, Ping Zhu
Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trial. Signal transduction and targeted therapy 8 (1) (2023)
Ke Wang, Yong Zhang, Zhi-Nan Chen
Metabolic interaction: tumor-derived lactate inhibiting CD8 + T cell cytotoxicity in a novel route. Signal transduction and targeted therapy 8 (1) (2023)
Jiao Wu, Liang Chen, Chuan Qin, Fei Huo, Xue Liang, Xu Yang, Kui Zhang, Peng Lin, Jiangning Liu, Zhuan Feng, Jiansheng Zhou, Zhuo Pei, Yatao Wang, Xiu-Xuan Sun, Ke Wang, Jiejie Geng, Zhaohui Zheng, Xianghui Fu, Man Liu, Qingyi Wang, Zheng Zhang, Hui-Jie Bian, Ping Zhu, Zhi-Nan Chen
CD147 contributes to SARS-CoV-2-induced pulmonary fibrosis. Signal transduction and targeted therapy 7 (1) (2022)

Ke Wang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ke Wang